Panelists discuss how emerging DPP1 inhibitor therapies target neutrophil serine proteases to reduce neutrophilic inflammation and neutrophil extracellular trap formation in bronchiectasis. DPP1 ...
Starting a treatment plan can be a big relief when you live with bronchiectasis, an inflammatory condition in which the lungs’ airways (bronchi) are left permanently damaged and widened, and are less ...
Add Yahoo as a preferred source to see more of our stories on Google. Sep. 24—(StatePoint) Getting the correct treatment for bronchiectasis, a chronic lung condition affecting 350,000 to 500,000 ...
For the first time, people with bronchiectasis will have a treatment option. The U.S. Food and Drug Administration has approved Insmed's daily pill brensocatib, which will be sold under the brand name ...
The American College of Chest Physicians (CHEST) recently released a new clinical guideline on the management of adult ...
Panelists discusses how bronchiectasis differs from other respiratory diseases like asthma and COPD through symptoms, imaging findings, and pathophysiological mechanisms. Panelists discusses how the ...
WASHINGTON, July 1, 2026 /PRNewswire/ -- Today is World Bronchiectasis Day, an observance to raise awareness about a lesser-known chronic lung disease that affects between 350,000 and 500,000 adults ...
(StatePoint) Getting the correct treatment for bronchiectasis, a chronic lung condition affecting 350,000 to 500,000 adults nationwide, is necessary to slow disease progression and help prevent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results